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The present study was designed to investigate the eﬀect of Rubia cordifolia (Rubiaceae) against experimentally induced gastric
ulcer and compare activity with its fractions by employing aspirin plus pylorus-ligated ulcer screening model in Wistar rats. Total
acidity, volumeofgastricacid secretion,totalacidoutput, andpepsin activity showsigniﬁcantreduction, when compared with the
control group. The present study conﬁrmed that chloroform fraction showed the signiﬁcant activity at lower doses compared to
parent extract. The mechanism can be attributed to decrease in gastric acid secretary activity along with strengthening of mucosal
defensive mechanism by prostaglandin synthesis and antioxidant potential.
1.Introduction
Rubia cordifolia Linn. (Rubiaceae) was popularly known as
“Indian madder”. It is an important ingredient of many
ayurvedic preparations. Roots are traditionally used as anti-
inﬂammatory, antiulcer, antidysenteric, and blood puriﬁer,
as well as various chemical constituents like anthraquinones,
iridoid glycoside, bicyclic hexapeptides, and triterpenes have
been isolated and identiﬁed from the plant [1]. Peptic ulcer
is one of the major gastrointestinal disorders, which occur
due to an imbalance between the oﬀensive (gastric acid
secretion) and defensive (gastric mucosal integrity) factors
[2]. Consequently, reduction of gastric acid production as
well asreinforcement ofgastric mucosalproductionhasbeen
the major approaches for therapy of peptic ulcer disease.
Prostaglandins are synthesized by the gastric mucosa and
are known to inhibit the secretion of gastric acid and
stimulate the secretion of mucus and bicarbonate. Also,
there is evidence concerning the participation of reactive
oxygen species in the etiology and pathophysiology of ulcer
[3]. The objective of the present study was to investigate
the gastroprotective and antioxidant activities of methanolic
extract of roots of R. cordifolia and its chloroform and
residual fractions by using aspirin plus pylorus ligation
model.
2.Materialand Methods
2.1. Plant Material and Extraction. Roots of Rubia cordifolia
were collected from Bhimashankar Hills (Ghat regions of
the sahyandri hills), Taluka Khed, District Pune, and Maha-
rashtra, in the month of August. The plant was identiﬁed
and authenticated from Regional Research Institute (AY)
Kothrud, Pune, by Dr. (Mr.) Rajesh Dabur, research oﬃcer,
asSpecimenVoucherno.645wasdepositedattheherbarium
of the RRI for future reference.
It was shade dried, powdered, and extracted with meth-
anol. The yield was 12.5%. It was then vacuum dried, and
half of the methanolic extract was successively fractionate
with chloroform (yield = 24.7%) using continuous soxhlet
apparatus. Parent extract (ME), along with chloroform
fraction (CF) and its residual fraction (RF), was used for the
further experimental model.
2.2. Drugs and Chemicals. Alcian blue, disodium hydrogen
phosphate, 5,5-dithio bis(2-nitro Benzoic acid), EDTA,
magnesium chloride hexahydrate crystals, phenolphthalein,
sodium acetate trihydrate, sodium bicarbonate, sucrose, tris
buﬀer tris buﬀer (Research Lab, Mumbai), bovine serum
albumin (Himedia Pvt. Ltd., Mumbai), copper sulphate2 Evidence-Based Complementary and Alternative Medicine
(QualigensFineChemicals,Mumbai),Folin-Ciocalteu’sphe-
nol reagent (Loba Chemicals, Mumbai), potassium dihydro-
gen orthophosphate (Pure Chemical. Laboratories, Pune),
sodium carbonate anhydrous (Qualigens Fine Chemicals,
Mumbai), thiobarbituric acid (Spectrochem Pvt. Ltd., Bom-
bay) trichloroacetic acid (Universal Laboratories Pvt. Ltd.,
Mumbai), tyrosine (Central Drug House P. Ltd., Bombay)
saline (Mareck Hariyala, Gujarat) ketamine hydrochloride
injection (Themis Medicare Ltd., Uttarakhand), aspirin
(USV Ltd., Mumbai), and ranitidine (GlaxoSmithKline
Pharmaceuticals Ltd., Mumbai)
2.3. Animals. Wistar rats weighing between 150–225g were
used for the study. Animals were maintained under con-
trolled conditionsoftemperature26±2◦C, relative humidity
44%–56%, and photoschedule (12hr light and 12hr dark).
Animals were provided with standard pellet diet (Amrut
Feeds, Mumbai, India) and water ad libitum. Institutional
Animal Ethics Committee approved the experimental pro-
tocol (198/99/CPCSEA). The pharmacological work was
carried out as per norms of CPCSEA (Committee for the
Purpose of Control and Supervision of Experiments on
Animals).
2.4. Acute Toxicity Studies. Rats were kept overnight fasting
prior to drug administration. A total of nine animals were
divided in three groups of three animals in each, which
received a single oral dose (2000mg/kg, b.w.) of methanolic
extract of roots of Rubia cordifolia (ME), its chloroform
fraction (CF), and residual fraction (RF), respectively. After
theadministration ofME,CF,and RF,animals wereobserved
individually and continuously for 30min, 2hr, and 24hr
after dosing, periodically (with special attention during the
ﬁrst 4hr) and daily thereafter for a period of 14 days. Once
daily cage side observations included changes in skin and
fur, eyes, andmucousmembrane (nasal) and also respiratory
rate, circulatory (heart rate and blood pressure), autonomic
(salivation, lacrimation, perspiration, piloerection, urinary
incontinence, and defecation), and central nervous system
(ptosis, drowsiness, gait, tremors, and convulsion) changes.
Mortality, if any, was determined over a period of 2 weeks
[4].
2.5. Selection of Dose of the Extract. LD50 was done as
per OECD guidelines for ﬁxing the dose for biological
evaluation. The LD50 of the extract as per OECD guidelines
falls under class four values with no signs of acute toxicity
at 2000mg/kg. The biological evaluations of ME was carried
out at doses of 100, 200, and 400mg/kg body weight, and CF
and RF are the fractions of ME, and it was given in the doses
of 50, 100, and 200mg/kg body weight, to compare the eﬀect
of fractions against parent extract in low doses.
2.6. Experimental Procedure
2.6.1. Study of Antiulcer Activity Using Aspirin Plus Pylorus
Ligation Method. Methanolic extract, its chloroform and
residual fraction of Rubia cordifolia, aspirin, and standard
antiulcer drug, ranitidine, were prepared in 1% sodium
carboxy methyl cellulose (NaCMC) suspension as vehicle
and administered orally once daily at a volume of 10ml/kg
body weight. The animals were divided into twelve groups,
consisting of six each. Group I represented the normal
control group, which received 10ml/kg body weight of vehi-
cle (NaCMC 1%, p.o.). Group II represented the ulcerated
control group, which received aspirin alone (200mg/kg,
p.o.). Group III represented the standard group, which
received ranitidine orally at the dose of 10mg/kg body
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orally at the doses of 100, 200, and 400mg/kg body weight,
respectively, Groups VII, VIII, and IX received CF orally at
the dosesof50,100,and 200mg/kgbody weight, respectively,
Groups X, XI, and XII received RF orally at the doses of
50,100, and 200mg/kg body weight, respectively, for 7 days.
From days 5 to 7, animals of all the groups received aspirin
orally as an aqueous suspension at a dose of 200mg/kg,
2hr after the administration of respective drug treatment.
Animals in all the groups were fasted for 18hr after the
respective assigned treatment and were anaesthetised with
ketamine hydrochloride (50mg/kg, i.p.). Four hours after
pylorus ligation, the rats were sacriﬁced and the stomach was
removed and observed for ulcers [5].
Ulcer score: the numbers of ulcers were counted using
magnifying lenses. Each ulcer was then measured with a
vernier calliper to assess the diameter. Ulcer index was
determined by scoring method of Suzuki et al. (1976).
The percent protection with each test drug dose was also
calculated by the following formula [6]:
%P r o t e c t i o n=
(UI control − UI treated) × 100
(UI control)
,( 1 )
where UI stands for ulcer index.
2.7. Eﬀects on Gastric Acid Secretion. The gastric content of
each stomach obtained from the pylorus was centrifuged at
2500rpm for 20min at 4◦C; the volume of the supernatant
(mL) and the pH value were measured. The volume was
expressed as ml per 100gb.w. [7]. An aliquot of 1mL
gastric juicewas used to determine acidity and was expressed
as meq/L [8].The peptic activity was determined by using
bovine serum albumin as a substrate and expressed in terms
of the amount (μmoles) of liberated L-tyrosine [7]. The
protein content was estimated with Folin’s phenol reagent at
750nm [9].
2.8. Gastric Wall Mucus (Barrier Mucus) Determination. The
glandular segments from stomach was transferred imme-
diately to 10mL of 0.1%, w:v alcian blue solution. After
immersion for 2h, excess dye was removed by two successive
rinses with 10mL of 0.25M sucrose, ﬁrst for 15min and
then for 45min. Dye complexed with gastric wall mucus
was extracted with10mL of 0.5M magnesium chloride by
shaking intermittently for 1min at 30mins intervals for 2hr.
The resulting blue solution was shaken vigorously with an
equal volume of diethyl ether, and then the emulsion was
centrifuged at 3000rpm for 10min, and the absorbance ofEvidence-Based Complementary and Alternative Medicine 3
the aqueouslayer against blank standard MgCl2 solution was
recorded at 580nm. The quantity of alcian blue recovered
from per gram of net glandular tissue was then calculated
[10].
2.9. Study of Antioxidant Activity. The animals were then
sacriﬁced, and the stomach was removed, processed, and
homogenized in Tris buﬀer (10mM, pH 7.4) at a concen-
tration of 10% (w/v). The homogenates were centrifuged
at 10,000 × ga t4 ◦C for 20min, using Remi C-24 high-
speed cooling centrifuge. The clear supernatant was used for
the assays of lipid peroxidation (MDA content), endogenous
antioxidant enzymes superoxide dismutase (SOD) and cata-
lase (CAT) and reduced glutathione (GSH) [3].
2.10. Statistical Analysis. Results of all above estimations
have been expressed in terms of mean ±SEM. Test and
standard groups were compared with control group. Statis-
tical comparison was performed using analysis of variance
(ANOVA) followed by Turkey’s test.
3.Results
3.1. Study of Gastroprotective Eﬀect on Aspirin plus Pylorus
Ligation Method. The ulcerated control group showed the
ulcer index 80.63 ± 3.88, and the maximum numbers of
ulcers were of the ulcer score 5 and 10, and also a number
of perforated ulcers (Score 25) were observed.
Methanolic extract of R. Cordifolia was found to produce
a decrease in ulcer index in the of 400mg/kg dose. But
chloroform fraction (CF) found to produce signiﬁcant (P<
.001) decrease in the ulcer index in all three doses, and
residual fraction (RF) showed nonsigniﬁcant changes in
the ulcer index. The total acidity and total acid output
were also signiﬁcantly (P<. 01) reduced in all three
doses of CF as compared to pylorus-ligated control group.
Control group showed signiﬁcant (P<. 001) decrease
in mucin content compared to normal group. CF showed
maximum signiﬁcant (P<. 001) increase in mucin content
ofstomachascomparedtoME(P<. 01),whereasRFshowed
signiﬁcant change at higher dose only. ME and CF groups
showed a signiﬁcant (P<. 001) decrease in the pepsin and
protein content compared to control group. RF group shows
nonsigniﬁcant results for protein content and signiﬁcance in
pepsin content at higher dose only (Table 1).
3.2. Study of In Vivo Antioxidant Activity. Aspirin plus
pylorus-ligated control group was found to increase lipid
peroxidation and decrease SOD, catalase, and reduced glu-
tathione levels, thus leading to oxidative stress. ME and CF
showed signiﬁcant (P<. 001)reductioninlipidperoxidation
and increase in the catalase, SOD, and content of reduced
glutathione.
Ranitidine (10mg/kg) was found to produce signiﬁcant
(P<. 001) reduction in ulcer index. It also reduces the
total acidity, total acid output, pepsin content, and protein
content, whereas mucin content increased as compared to
the pylorus-ligated control group. It also showed signiﬁcant
(P<. 001) increase in the SOD, catalase, and reduced
glutathione, whereas no as such eﬀect on lipid peroxidation
(Table 2).
4.Discussionand Conclusions
The use of various herbal medicines for various disorders is
now widely accepted. However, both in the clinical practice
and diagnostic and therapeutic, these systems fail to ﬁnd
exacting correlates with those in modern medicines. The
disease classiﬁcation is essentially based on symptomatology
andtherapydesignedwithvariedpreoccupations.Itbecomes
diﬃcult,therefore,todeﬁnewith certaintythepharmacolog-
ical activity to be evaluated with respect to the traditionally
prescribed use of an indigenous drug. Nevertheless, pre-
sumptions based on nature of traditional use and evaluation
of speciﬁc beneﬁcial activity of indigenous drugs have been
found to be successful approach in medicinal plant research
[8].
The Rubia cordifolia has been reported the presence
of alkaloids, phytosterols, saponins, tannins, carbohydrates,
phenolic compounds, anthraquinone glycosides, and triter-
penoids [1]. The chloroform fraction mainly contains trit-
erpenoids in major concentration [11]. Pentacyclic triter-
penoids, in addition to their anti-inﬂammatory properties,
are also known to promote mucus secretion. Thus, mucus
secreting potential and subsequent wound healing eﬀect of
the extract of Rubia cordifolia may be linked to the presence
of triterpenes. In addition, triterpenoids are also reported to
begoodantioxidant,such asα-and β-amirins, oleanolicacid,
ursolic acid, and lupeol and glycirretinic acid [12]. Oleana-
nes, rubicoumaric acid, rubifolic acid, and various other
typesoftriterpenoidswereisolatedfromchloroformfraction
of methanolic extract of roots of Rubia cordifolia [11, 13].
Aspirin causes mucosal damage by interfering with
prostaglandin synthesis. Disturbances in gastric secretion,
damage to gastric mucosa, alteration in permeability, gastric
mucus depletion, increase in the pepsin and protein content,
and generation of free radical production are reported to
be the pathogenic eﬀects of aspirin plus pylorus-ligated
ulcer [14]. Reactive oxygen species are also involved in the
pathogenesis of pylorus ligation ulcer [15]. Pylorus ligation-
induced ulcers are due to accumulation of gastric acid and
pepsin which lead to autodigestion of gastric mucosa and
breakdown of gastric mucosal barrier. The increase in the
protein content of the gastric juice in untreated ulcer group
indicates the damage to the gastric mucosa as a result of
plasma proteins leak into the gastric juice [16].
Mucus is secreted by the mucus neck cells and coats
the gastric mucosa, thereby preventing physical damage and
back diﬀu s i o no fh y d r o g e ni o n s[ 17]. The decreased mucin
secretion in control rats indicates the decreased ability of
the mucosal membrane to protect the mucosa from physical
damage and back diﬀusion of hydrogen ions. Depletion
of the gastric wall mucus has been signiﬁcantly (P<
.001) prevented by chloroform fraction. The total acidity
and total acid output signiﬁcantly (P<. 001) decreased
when compared with control group. This data indicates that4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀect of R. cordifolia on gastric acid secretion and ulcer index.
S r . N o . 1234567891 0 1 1 1 2
Group Normal Control Standard ME 100 ME 200 ME 400 CF 50 CF 100 CF 200 RF 50 RF 100 RF 200
Ulcer Index
(%protection) — 80.63 ±
3.88
21.88 ±
2.01
∗∗∗
(72.86)
68.82 ±
2.22NS
(14.64)
66.24 ±
4.48NS
(17.84)
54.42 ±
3.54
∗∗
(32.50)
52.39 ±
1.51
∗∗
(35.02)
40.82 ±
3.87
∗∗∗
(49.37)
30.87 ±
2.24
∗∗∗
(61.71)
72.89 ±
3.18NS
(9.59)
70.82 ±
2.26NS
(12.16)
69.65 ±
2.15NS
(13.61)
Pepsin (nmols
of
tyrosine/mL)
— 21.63 ±
1.21
4.62 ±
1.03
∗∗∗
15.85 ±
1.62
NS
13.32 ±
1.41
∗∗
11.82 ±
1.02
∗∗∗
13.82 ±
1.39
∗∗
11.28 ±
1.22
∗∗∗
10.62 ±
1.36
∗∗∗
17.27 ±
0.71
NS
15.62 ±
1.66
NS
14.27 ±
2.19
∗
Protein
(μg/mL) — 174.47 ±
9.03
99.42 ±
2.61
∗∗∗
148.26 ±
5.38
∗
131.27 ±
1.63
∗∗∗
129.53 ±
2.82
∗∗∗
130.62 ±
2.11
∗∗∗
127.26 ±
1.51
∗∗∗
114.42 ±
3.31
∗∗∗
174.56 ±
6.61
NS
166.36 ±
10.95
NS
149.26 ±
2.55
NS
Mucin
Content (μgo f
alcian blue/g
wet tissue)
110.2 ±
1.31
61.28 ±
2.22a
64.49 ±
1.61NS
71.27 ±
1.41NS
75.48 ±
2.15
∗∗
77.27 ±
3.16
∗∗
74.83 ±
2.41
∗
81.67 ±
2.97
∗∗∗
86.26 ±
3.73
∗∗∗
58.28 ±
2.63NS
68.84 ±
2.01NS
75.28 ±
2.28
∗
Total Acidity
(meq/L/4hr)
1088.28
± 22.29
1939.21
± 42.71
b
1195.26
± 37.03
1844.82
±
28.77NS
1775.82
± 29.26∗
1533.62
±
15.72∗∗
1545.82
±
40.83∗∗
1340.32
±
41.94∗∗
1226.42
±
38.14∗∗
2070.42±
22.49
NS
1787.42±
73.38
NS
1648.82
±
29.64∗∗
Total acid
Output
(meq/L/4hr)
2459.08
± 81.97
9318.16
±
328.23b
3068.32
± 103.24
8398.11±
428.97NS
7280.47
±
708.72∗∗
6180.48
±
172.84∗∗
7574.04
±
539.46∗
5671.92
±
308.91∗∗
4741.44
±
41.17∗∗
7871.67±
451.58NS
7835.26±
414.12NS
7612.26
±
359.52∗
N = 6n o r m a lg r o u p = vehicle Na CMC 1% (10ml/kg, p.o.).
Valuesareexpressedasmean±SEM.Control group wascompared withnormal group. Testand standard groups werecompared withcontrol group. Statistical
comparisonwas performed using analysisof variance (ANOVA) followed by Turkey’s test. aP <. 001; bP <. 01, when compared with normal group. ∗P<. 05;
∗∗P<. 01; ∗∗∗P<. 001; NS: nonsigniﬁcant, when compared with control groups.
ME100, 200, and 400—methanolic extract of Rubia cordifolia 100, 200, and 400mg/kg, p.o,. respectively, CF50,100, and 200—chloroform fraction of Rubia
cordifolia 50, 100, and 200mg/kg, p.o., respectively, RF50,100, and 200—residual fraction of Rubia cordifolia 50, 100, and 200mg/kg, p.o., respectively.
Table 2: Eﬀect of R. cordifolia on antioxidant parameters in stomach of aspirin + pylorus-ligated rats.
123456789 1 0 1 1 1 2
Group Normal Control Standard ME 100 ME 200 ME 400 CF 50 CF 100 CF 200 RF 50 RF 100 RF 200
SOD
(Units/gm of
wet tissue)
204.4 ±
3.61
89.4 ±
2.94a
125.2 ±
2.38∗∗∗
104.48 ±
2.09NS
105.24 ±
1.48NS
112.36 ±
2.94∗∗∗
110.84 ±
3.72∗∗
132.92 ±
2.65∗∗∗
172.06 ±
7.22∗∗∗
98.54 ±
3.57NS
102.68 ±
1.76NS
106.14 ±
2.2∗
CAT
(Units/gm of
wet tissue)
45.97 ±
2.12
13.04 ±
1.24a
40.35 ±
1.25∗∗∗
18.96 ±
1.72NS
23.73 ±
1.26∗∗
26.3 ±
1.47∗∗∗
24.3 ±
1.86∗∗
29.73 ±
2.05∗∗∗
34.4 ±
2.02∗∗∗
17.18 ±
1.62NS
18.84 ±
1.98NS
20.35 ±
1.95NS
GSH
(nmols/gm of
wet tissue)
218.4 ±
6.43
94.9 ±
3.42
a
142.9 ±
6.72∗∗∗
122.22 ±
4.4∗
127.28 ±
4.72∗∗
150.52 ±
3.84∗∗∗
123.96 ±
4.97∗∗
155.4 ±
4.52∗∗∗
176.42 ±
4.59∗∗∗
108.28 ±
4.8
NS
111.66 ±
5.7
NS
120.4 ±
4.81∗
LPO (nmols
of MDA/gm
of wet tissue)
139.68 ±
4.27
258.48 ±
3.72
a
235.64 ±
6.19∗
236.8 ±
6.85
NS
229.24 ±
5.38∗∗
183.46 ±
3.76∗∗∗
199.66 ±
4.74∗∗∗
177.76 ±
3.95∗∗∗
155.94 ±
2.73∗∗∗
244.94 ±
2.75
NS
237.76 ±
3.28
NS
230.1 ±
3.9∗∗
N = 6n o r m a lg r o u p = vehicle Na CMC 1% (10ml/ kg, p.o.).
Values are expressed as mean ± SEM. Control group was compared with normal group. Test and standard groups were compared with control group.
Statisticalcomparison was performed usinganalysisof variance (ANOVA) followedby Turkey’s test. aP <. 001,when compared withnormal group. ∗P<. 05;
∗∗P<. 01; ∗∗∗P<. 001; NS: nonsigniﬁcant, when compared with control groups.
ME100, 200, and 400—methanolic Extract of Rubia cordifolia 100, 200, and 400mg/kg, p.o., respectively, CF50,100, and 200—chloroform fraction of Rubia
cordifolia 50, 100, and 200 mg/kg, p.o., respectively, RF50,100, and 200—residual fraction of Rubia cordifolia 50, 100, and 200mg/kg, p.o., respectively.
theantisecretory propertyinvolvedwiththeantiulceractivity
[18]. Reduction in ulcer index, total acidity, protein, and
pepsin content of the gastric ﬂuid and increase in the mucin
content indicate the cytoprotective eﬀect of R. cordifolia.
Lipid peroxidation is a free radical-mediated process,
which has been implicated in a variety of disease states. It
involves the formation and propagation of lipid radicals, the
uptake of oxygen, and rearrangement of double bonds in
unsaturated lipids which eventually results in destruction
of membrane lipids. Therefore, it is not surprising that
membrane lipids are susceptible to peroxidative attack. In
the stomach tissue of rats of aspirin plus pylorus-ligatedEvidence-Based Complementary and Alternative Medicine 5
control group, the MDA level, a lipid peroxidation product,
increased signiﬁcantly compared to the normal group. CF
group decreases the MDA level in gastric tissue signiﬁcantly
(P<. 001) than standard (ranitidine) group. Preventive
antioxidants, such as superoxide dismutase (SOD) and
catalase (CAT) enzymes, are the ﬁrst line defence against
reactive oxygen species. Reduced glutathione is a major low
molecular weight scavenger of free radicals in the cytoplasm
and an important inhibitor of free radical-mediated lipid
peroxidation [15]. Administration of ME at higher dose
(400mg/kg) and CF showed signiﬁcant increase in SOD,
catalase and reduced glutathione levels as compared to the
control animals, which suggest the eﬃcacy in preventing free
radical-induced damage.
The above results demonstrated that chloroformfraction
was more potent than parent methanol extract at lower
dose. As per the phytochemical evidences revealed that the
chloroform fraction mainly contains triterpenoids, maybe
thisactivitywasbecauseoftriterpenoids.Astriterpenoidsare
reported as a good antiulcer and antioxidant compound.
It could be concluded that Rubia cordifolia has both
gastroproctective and ulcer-healing properties probably by
the two mechanisms: (1) by increasing defensive gastric
mucosa and prostaglandin synthesis: (2) Due to antioxidant
potential of drug.
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